Fibrosis & Cirrhosis
AASLD 2014: Many Hepatitis C Patients with Cirrhosis or Advanced Fibrosis Face Liver Failure
- Details
- Category: HCV Disease Progression
- Published on Friday, 12 December 2014 00:00
- Written by Liz Highleyman
Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within 5 years, and 23% and 11%, respectively, died, according to a study presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meetinglast month in Boston. These findings underscore the urgent need for treatment for such individuals.
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
HCV Genotype 3, Hispanic Ethnicity Linked to Higher Risk of Cirrhosis, Liver Cancer
- Details
- Category: HCV Disease Progression
- Published on Wednesday, 08 October 2014 00:00
- Written by Liz Highleyman
People with hepatitis C virus (HCV) genotype 3 are more likely to progress to liver cirrhosis and hepatocellular carcinoma (HCC) compared to people with other genotypes, according to a recent report. A related study found that people of Hispanic/Latino ethnicity are also more likely to develop advanced liver disease.
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
DDW 2014: Drinking More Coffee Is Associated with Less Liver Fibrosis
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 06 May 2014 00:00
- Written by Liz Highleyman
People with hepatitis C who drink more cups of coffee per day may have a lower likelihood of developing advanced liver fibrosis or cirrhosis -- but only if it contains caffeine, and tea does not appear to have a similar effect, according to a study presented at the Digestive Disease Week (DDW 2014) meeting this week in Chicago.